Autonomix Medical (AMIX) Competitors $1.30 -0.07 (-5.11%) Closing price 03:56 PM EasternExtended Trading$1.30 0.00 (0.00%) As of 04:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock AMIX vs. NXGL, PETV, IRIX, XAIR, MHUA, VVOS, LFWD, BTCY, WOK, and ICUShould you be buying Autonomix Medical stock or one of its competitors? The main competitors of Autonomix Medical include NEXGEL (NXGL), PetVivo (PETV), IRIDEX (IRIX), Beyond Air (XAIR), Meihua International Medical Technologies (MHUA), Vivos Therapeutics (VVOS), ReWalk Robotics (LFWD), Biotricity (BTCY), WORK Medical Technology Group LTD Ordinary Shares (WOK), and SeaStar Medical (ICU). These companies are all part of the "medical equipment" industry. Autonomix Medical vs. Its Competitors NEXGEL PetVivo IRIDEX Beyond Air Meihua International Medical Technologies Vivos Therapeutics ReWalk Robotics Biotricity WORK Medical Technology Group LTD Ordinary Shares SeaStar Medical Autonomix Medical (NASDAQ:AMIX) and NEXGEL (NASDAQ:NXGL) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, media sentiment, earnings, risk, analyst recommendations, dividends, valuation and community ranking. Which has better earnings and valuation, AMIX or NXGL? NEXGEL has higher revenue and earnings than Autonomix Medical. NEXGEL is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAutonomix MedicalN/AN/A-$15.43M-$7.47-0.17NEXGEL$10.23M1.92-$3.16M-$0.45-5.69 Do analysts recommend AMIX or NXGL? Autonomix Medical presently has a consensus price target of $16.50, indicating a potential upside of 1,169.23%. Given Autonomix Medical's stronger consensus rating and higher probable upside, research analysts plainly believe Autonomix Medical is more favorable than NEXGEL.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Autonomix Medical 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00NEXGEL 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is AMIX or NXGL more profitable? Autonomix Medical has a net margin of 0.00% compared to NEXGEL's net margin of -52.60%. NEXGEL's return on equity of -71.19% beat Autonomix Medical's return on equity.Company Net Margins Return on Equity Return on Assets Autonomix MedicalN/A -212.48% -161.13% NEXGEL -52.60%-71.19%-34.79% Do institutionals and insiders believe in AMIX or NXGL? 10.8% of Autonomix Medical shares are held by institutional investors. Comparatively, 2.2% of NEXGEL shares are held by institutional investors. 32.4% of Autonomix Medical shares are held by insiders. Comparatively, 20.5% of NEXGEL shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the media favor AMIX or NXGL? In the previous week, NEXGEL had 2 more articles in the media than Autonomix Medical. MarketBeat recorded 4 mentions for NEXGEL and 2 mentions for Autonomix Medical. Autonomix Medical's average media sentiment score of 0.43 beat NEXGEL's score of -0.28 indicating that Autonomix Medical is being referred to more favorably in the media. Company Overall Sentiment Autonomix Medical Neutral NEXGEL Neutral Does the MarketBeat Community believe in AMIX or NXGL? Autonomix Medical received 1 more outperform votes than NEXGEL when rated by MarketBeat users. Likewise, 100.00% of users gave Autonomix Medical an outperform vote while only 50.00% of users gave NEXGEL an outperform vote. CompanyUnderperformOutperformAutonomix MedicalOutperform Votes2100.00% Underperform VotesNo VotesNEXGELOutperform Votes150.00% Underperform Votes150.00% Which has more risk & volatility, AMIX or NXGL? Autonomix Medical has a beta of -3.46, indicating that its stock price is 446% less volatile than the S&P 500. Comparatively, NEXGEL has a beta of 0.52, indicating that its stock price is 48% less volatile than the S&P 500. SummaryAutonomix Medical beats NEXGEL on 10 of the 17 factors compared between the two stocks. Get Autonomix Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for AMIX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AMIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AMIX vs. The Competition Export to ExcelMetricAutonomix MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.61M$4.32B$5.58B$8.49BDividend YieldN/A42.67%5.28%4.17%P/E Ratio-0.1027.8027.1819.64Price / SalesN/A68.36408.37152.20Price / CashN/A51.0838.3234.64Price / Book0.165.746.974.60Net Income-$15.43M$66.95M$3.23B$248.06M7 Day Performance-12.16%-2.71%-0.84%-0.97%1 Month Performance-29.73%14.90%7.86%3.56%1 Year Performance-95.78%17.90%31.51%12.68% Autonomix Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AMIXAutonomix Medical2.7053 of 5 stars$1.30-5.1%$16.50+1,169.2%-95.1%$3.61MN/A-0.101Short Interest ↑NXGLNEXGEL1.0896 of 5 stars$2.42+10.5%N/A-3.9%$18.53M$10.23M-4.1710Gap UpPETVPetVivoN/A$0.76-1.0%N/A+9.5%$18.39M$1.05M-1.6820Gap UpIRIXIRIDEX0.5293 of 5 stars$0.97-2.7%N/A-54.8%$16.34M$48.80M-1.45120News CoverageShort Interest ↑Gap UpXAIRBeyond Air4.4698 of 5 stars$0.19+1.2%$1.50+702.1%-85.3%$16.15M$3.02M-0.1870Upcoming EarningsMHUAMeihua International Medical Technologies1.7005 of 5 stars$0.59+12.1%N/A-50.0%$14.90M$96.91M0.00620Short Interest ↓VVOSVivos Therapeutics1.5753 of 5 stars$2.39-0.4%$4.82+101.5%-9.0%$14.08M$14.63M-0.42160Short Interest ↑LFWDReWalk Robotics2.5371 of 5 stars$1.25+2.0%$9.00+620.0%-75.6%$13.76M$25.41M-0.5060Short Interest ↑Gap UpBTCYBiotricityN/A$0.51-3.8%N/A-48.5%$12.71M$12.06M-0.4740Gap UpWOKWORK Medical Technology Group LTD Ordinary SharesN/A$0.84-5.3%N/AN/A$12.26M$11.51M0.00226Positive NewsGap DownICUSeaStar Medical0.3486 of 5 stars$1.15-2.5%N/A-66.8%$11.91M$428K-0.102Short Interest ↑ Related Companies and Tools Related Companies NEXGEL Competitors PetVivo Competitors IRIDEX Competitors Beyond Air Competitors Meihua International Medical Technologies Competitors Vivos Therapeutics Competitors ReWalk Robotics Competitors Biotricity Competitors WORK Medical Technology Group LTD Ordinary Shares Competitors SeaStar Medical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AMIX) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Autonomix Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Autonomix Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.